TET1 mutations as a predictive biomarker for immune checkpoint inhibitors in colon adenocarcinoma

BACKGROUND: The ten-eleven translocation 1 (TET1), which is essential for active DNA demethylation, plays a multifaceted role in the pathogenesis of colorectal cancer. The study has demonstrated the association of TET1 mutations with a high response to immune checkpoint inhibitors (ICIs) in diverse...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Tianzhu, Wang, Xiaoxuan, Du, Furong, Hu, Xiangjing, Sun, Fujun, Song, Chao, Zhao, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991851/
https://www.ncbi.nlm.nih.gov/pubmed/35395805
http://dx.doi.org/10.1186/s12957-022-02581-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991851/
https://www.ncbi.nlm.nih.gov/pubmed/35395805
http://dx.doi.org/10.1186/s12957-022-02581-7

Ejemplares similares